Mirum Pharmaceuticals (MIRM) Interest Expenses (2019 - 2026)
Mirum Pharmaceuticals (MIRM) posted quarterly Interest Expenses of $26.7 million for Q1 2026, down 79.65% year-over-year from $131.4 million in Q1 2025, and up 815.98% quarter-over-quarter from -$3.7 million in Q4 2025.
Mirum Pharmaceuticals (MIRM) Interest Expenses (2019 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Interest Expenses history runs 8 years deep, the most recent figure standing at $26.7 million for Q1 2026.
- In Q1 2026, Interest Expenses fell 79.65% year-over-year to $26.7 million; the TTM figure through Mar 2026 stood at $26.7 million (down 79.65% YoY), while the FY2025 annual figure was $480.0 million, up 105.86% from the prior year.
- Interest Expenses for Q1 2026 stood at $26.7 million, up from -$3.7 million in the prior quarter.
- The five-year high for Interest Expenses was $293.7 million in Q2 2025, with the low at -$10.5 million in Q4 2023.
- The 5-year median for Interest Expenses is $27.3 million (2022), against an average of $69.9 million.
- Peak annual rise in Interest Expenses reached 3913.88% in 2023, while the deepest fall reached 338.94% in 2023.
- Mirum Pharmaceuticals' Interest Expenses stood at $4.4 million in 2022, then tumbled by 338.94% to -$10.5 million in 2023, then jumped by 160.45% to $6.3 million in 2024, then tumbled by 159.05% to -$3.7 million in 2025, then jumped by 815.98% to $26.7 million in 2026.
- Business Quant data shows MIRM's Interest Expenses at $26.7 million in Q1 2026, -$3.7 million in Q4 2025, and $131.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Mirum Pharmaceuticals | 6.52 Bn | 6.08 Bn | 145.90 Mn | 746.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 746.56 Mn |
| Jun 30, 2026 | 746.56 Mn |
| Mar 31, 2026 | 26.74 Mn |
| Mar 31, 2026 | 26.74 Mn |
| Dec 31, 2025 | -3.74 Mn |
| Dec 31, 2025 | -3.74 Mn |
| Sep 30, 2025 | 131.41 Mn |
| Sep 30, 2025 | 131.41 Mn |
| Jun 30, 2025 | 293.68 Mn |
| Jun 30, 2025 | 293.68 Mn |
| Mar 31, 2025 | 131.41 Mn |
| Mar 31, 2025 | 131.41 Mn |
| Dec 31, 2024 | 6.33 Mn |
| Dec 31, 2024 | 6.33 Mn |
| Sep 30, 2024 | 154.98 Mn |
| Sep 30, 2024 | 154.98 Mn |
| Jun 30, 2024 | 23.58 Mn |
| Jun 30, 2024 | 23.58 Mn |
| Mar 31, 2024 | 150.38 Mn |
| Mar 31, 2024 | 150.38 Mn |